ADINAZOLAM PHARMACOKINETICS AND BEHAVIORAL-EFFECTS FOLLOWING ADMINISTRATION OF 20-60 MG ORAL DOSES OF ITS MESYLATE SALT IN HEALTHY-VOLUNTEERS

被引:28
作者
FLEISHAKER, JC
PHILLIPS, JP
机构
关键词
D O I
10.1007/BF00634449
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:34 / 39
页数:6
相关论文
共 17 条
[1]  
AMSTERDAM JD, 1986, PSYCHOPHARMACOLOGY, V88, P484
[2]  
DUNNER D, 1987, J CLIN PSYCHOPHARM, V7, P170
[3]  
FLEISHAKER JC, 1989, IN PRESS PHARM RES
[4]  
GIBALDI M, 1982, PHARMACOKINETICS
[5]   TOLERANCE TO ALPRAZOLAM AFTER INTRAVENOUS BOLUS AND CONTINUOUS INFUSION - PSYCHOMOTOR AND EEG EFFECTS [J].
KROBOTH, PD ;
SMITH, RB ;
ERB, RJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (03) :270-277
[6]   PHARMACOLOGICAL PROFILE OF THE ANTI-DEPRESSANT ADINAZOLAM, A TRIAZOLOBENZODIAZEPINE [J].
LAHTI, RA ;
SETHY, VH ;
BARSUHN, C ;
HESTER, JB .
NEUROPHARMACOLOGY, 1983, 22 (11) :1277-1282
[7]  
PENG GW, 1986, PHARMACOL RES S, V3, pS108
[8]  
RANDT C, 1983, RANDT MEMORY TEST AD
[9]   THE EFFECT OF PROADIFEN ON THE METABOLISM OF ADINAZOLAM [J].
SETHY, VH ;
FRANCIS, JW ;
DAY, JS .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1986, 38 (08) :631-632
[10]   DETERMINATION OF BIOLOGICAL-ACTIVITY OF ADINAZOLAM AND ITS METABOLITES [J].
SETHY, VH ;
COLLINS, RJ ;
DANIELS, EG .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1984, 36 (08) :546-548